Endogenex Revenue and Competitors

Location

N/A

Total Funding

Medical

Industry

Employee Data

  • Endogenex has 26 Employees.(i)
  • Endogenex grew their employee count by 8% last year.

Endogenex's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A140%N/AN/A
#2
N/A1614%N/AN/A
#3
N/A11-8%N/AN/A
#4
N/A2414%N/AN/A
#5
N/A6219%N/AN/A
#6
N/A21422%N/AN/A
#7
$7.5M12725%N/AN/A
#8
N/A60-15%N/AN/A
#9
N/A95314%N/AN/A
#10
$1.7M70%N/AN/A
Add Company

What Is Endogenex?

Endogenex, in partnership with Mayo Clinic, aims to revolutionize treatment options for individuals with type 2 diabetes (T2D). Endogenex’s innovations focus on resetting the body’s metabolic signaling system by harnessing its natural regenerative capabilities to improve metabolic function. Through the development of the ReCET System and the novel application of precise, controlled, non-thermal pulsed electric fields, Endogenex is establishing a new era in treatment options for people living with T2D, helping patients regain control of their blood glucose levels and slow disease progression.\nEndogenex is a privately held, clinical-stage company based in Minneapolis, MN.

keywords:N/A

N/A

Total Funding

26

Number of Employees

N/A

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M26-4%N/A
#2
$6.7M2613%N/A
#3
$7.3M268%N/A
#4
$5.3M2618%N/A
#5
$1M26271%N/A